Dual-Inhibition of mTOR and Bcl-2 Enhances the Anti-tumor Effect of Everolimus against Renal Cell Carcinoma <i>In Vitro</i> and <i>In Vivo</i>Ayse Hande Nayman, Dilek Telci|Journal of Cancer|2019Cited by 44